肿瘤相关巨噬细胞在胃癌中的研究进展
Research Progress of Tumor-Associated Macrophages in Gastric Cancer
DOI: 10.12677/ACM.2023.134741, PDF,   
作者: 仝建宁, 王晓宇, 周浩楠：甘肃中医药大学第一临床医学院，甘肃 兰州；呼永华*：甘肃中医药大学第一临床医学院，甘肃 兰州；甘肃中医药大学附属医院肿瘤科，甘肃 兰州；兰州大学第二临床医学院，甘肃 兰州；陈 昊：兰州大学第二临床医学院，甘肃 兰州
关键词: 肿瘤相关巨噬细胞；胃癌；免疫微环境；Tumor-Associated Macrophages； Gastric Cancer； Immune Microenvironment
摘要: 肿瘤相关巨噬细胞在不同因子的作用下可以分化为经典活化型和交替活化型两种表型，两种表型对胃癌细胞的发生、发展发挥相反的作用，其中，M2型能够分泌多种趋化因子，抑制炎性反应的发生，促进血管和淋巴管形成。胃癌是常见的恶性消化道肿瘤，患者整体生存率还较低，因此寻找特异性的能够预测预后的因素，开发新的作用靶点迫在眉睫。鉴于此本文就肿瘤相关巨噬细胞在胃癌中的有关研究进行分析、综述，以期为改善胃癌患者预后，研发新型靶向药物提供新视角。
Abstract: Tumor-associated macrophages can differentiate into two phenotypes, classical activation and al-ternating activation under the action of different factors, and the two phenotypes play opposite roles on the occurrence and development of gastric cancer cells, among which M2 can secrete a va-riety of chemokines, inhibit the occurrence of inflammatory reactions, and promote the formation of blood vessels and lymphatic vessels. Gastric cancer is a common malignant digestive tract tumor, and the overall survival rate of patients is still low, so it is urgent to find specific factors that can predict prognosis and develop new targets. In view of this, this paper analyzes and reviews the rel-evant research of tumor-associated macrophages in gastric cancer, in order to provide a new per-spective for improving the prognosis of gastric cancer patients and developing new targeted drugs.
文章引用：仝建宁, 呼永华, 陈昊, 王晓宇, 周浩楠. 肿瘤相关巨噬细胞在胃癌中的研究进展[J]. 临床医学进展, 2023, 13(4): 5236-5241. https://doi.org/10.12677/ACM.2023.134741

参考文献

[1] Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[2] 王静, 丁鹏鹏, 王亚丹, 崔建芳, 王沧海, 刘红. T1M1期胃癌患者临床病理特征及预后生存分析[J]. 胃肠病学和肝病学杂志, 2021, 30(10): 1107-1111.
[3] Bejarano, L., Jordāo, M.J.C. and Joyce, J.A. (2021) Therapeutic Targeting of the Tumor Microenvironment. Cancer Discovery, 11, 933-959. [Google Scholar] [CrossRef] 
[4] Mantovani, A., Marchesi, F., Jaillon, S., et al. (2021) Tu-mor-Associated Myeloid Cells: Diversity and Therapeutic Targeting. Cellular & Molecular Immunology, 18, 566. [Google Scholar] [CrossRef] [PubMed]
[5] Yang, S., Liu, Q. and Liao, Q. (2020) Tumor-Associated Mac-rophages in Pancreatic Ductal Adenocarcinoma: Origin, Polarization, Function, and Reprogramming. Frontiers in Cell and Developmental Biology, 8, Article ID: 607209. [Google Scholar] [CrossRef] [PubMed]
[6] Ruytinx, P., Proost, P., Van Damme, J., et al. (2018) Chemo-kine-Induced Macrophage Polarization in Inflammatory Conditions. Frontiers in Immunology, 9, 1930. [Google Scholar] [CrossRef] [PubMed]
[7] Zeng, D., Li, M., Zhou, R., et al. (2019) Tumor Microenvironment Characterization in Gastric Cancer Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures. Cancer Immunology Research, 7, 737-750. [Google Scholar] [CrossRef] 
[8] Hardbower, D.M., Asim, M., Murray-Stewart, T., et al. (2016) Arginase 2 Deletion Leads to Enhanced M1 Macrophage Activation and Upregulated Polyamine Metabolism in Response to Helicobacter pylori Infection. Amino Acids, 48, 2375-2388. [Google Scholar] [CrossRef] [PubMed]
[9] Wang, Z., Yang, Y., Cui, Y., et al. (2020) Tumor-Associated Macrophages Regulate Gastric Cancer Cell Invasion and Metastasis through TGFβ2/NF-κB /Kindlin-2 Axis. Chinese Journal of Cancer Research, 32, 72-88. [Google Scholar] [CrossRef] [PubMed]
[10] Ostuni, R., Kratochvill, F., Murray, P.J., et al. (2015) Macrophages and Cancer: From Mechanisms to Therapeutic Implications. Trends in Immunology, 36, 229-239. [Google Scholar] [CrossRef] [PubMed]
[11] Achkovad, M. (2016) Role of the Colony-Stimulating Factor (CSF)/CSF-1 Receptor Axis in Cancer. Biochemical Society Transactions, 44, 333-341. [Google Scholar] [CrossRef] 
[12] Ma, F., Zhang, B., Ji, S., et al. (2019) Hypoxic Macrophage-Derived VEGF Promotes Proliferation and Invasion of Gastric Cancer Cells. Digestive Diseases and Sciences, 64, 3154-3163. [Google Scholar] [CrossRef] [PubMed]
[13] Liu, D., Wang, N., Sun, Y., et al. (2018) Expression of VEGF with Tumor Incidence, Metastasis and Prongnosis in Human Gastric Carcinoma. Cancer Biomarkers, 22, 693-700. [Google Scholar] [CrossRef] 
[14] Zhu, J., Zhi, Q., Zhou, B.P., et al. (2016) The Role of Tumor Associat-ed Macrophages in the Tumor Microenvironment: Mechanism and Functions. Anti-Cancer Agents in Medicinal Chemis-try, 16, 1133-1141. [Google Scholar] [CrossRef] [PubMed]
[15] Ma, Y.Y., He, X.J., Wang, H.J., et al. (2011) Interac-tion of Coagulation Factors and Tumor-Associated Macrophages Mediates Migration and Invasion of Gastric Cancer. Cancer Science, 102, 336-342. [Google Scholar] [CrossRef] [PubMed]
[16] Shen, Z.L., Yan, Y.C., Ye, C., et al. (2016) The Effect of Vasohibin-1 Expression and Tumor-Associated Macrophages on the Angiogenesis in Vitro and in Vivo. Tumor Biology, 37, 7267-7276. [Google Scholar] [CrossRef] [PubMed]
[17] 邱森, 孙淼淼, 陈奎生. 肿瘤相关巨噬细胞对肿瘤血管生成影响的研究进展[J]. 细胞与分子免疫学杂志, 2019, 35(5): 469-472.
[18] Liu, J.Y., Yang, X.J., Geng, X.F., et al. (2016) Prognostic Significance of Tumor-Associated Macrophages Density in Gastric Cancer: A Systemic Review and Meta-Analysis. Minerva Medica, 107, 314-321.
[19] Tauchi, Y., Tanaka, H., Kumamoto, K., et al. (2016) Tu-mor-Associated Macrophages Induce Capillary Morphogenesis of Lymphatic Endothelial Cells Derived from Human Gastric Cancer. Cancer Science, 107, 1101-1109. [Google Scholar] [CrossRef] [PubMed]
[20] Chen, H., Guan, R., Lei, Y., et al. (2015) Lymphangiogenesis in Gastric Cancer Regulated through Akt/mTOR-VEGF- C/VEGF-D Axis. BMC Cancer, 15, 103. [Google Scholar] [CrossRef] [PubMed]
[21] Pathria, P., Louis, T.L. and Varner, J.A. (2019) Targeting Tu-mor-Associated Macrophages in Cancer. Trends in Immunology, 40, 310-327. [Google Scholar] [CrossRef] [PubMed]
[22] Liu, Y., Ye, Y. and Zhu, X. (2019) MMP-9 Secreted by Tumor As-sociated Macrophages Promoted Gastric Cancer Metastasis through a PI3K/AKT/Snail Pathway. Biomedicine & Phar-macotherapy, 117, Article ID: 109096. [Google Scholar] [CrossRef] [PubMed]
[23] Eissmann, M.F., Dijkstra, C., Jarnicki, A., et al. (2019) IL-33-Mediated Mast Cell Activation Promotes Gastric Cancer through Macrophage Mobilization. Nature Communica-tions, 10, 2735. [Google Scholar] [CrossRef] [PubMed]
[24] Liu, X., Xu, D., Huang, C., et al. (2019) Regu-latory T Cells and M2 Macrophages Present Diverse Prognostic Value in Gastric Cancer Patients with Different Clinico-pathologic Characteristics and Chemotherapy Strategies. Journal of Translational Medicine, 17, 192. [Google Scholar] [CrossRef] [PubMed]
[25] Huang, Y.K., Wang, M., Sun, Y., et al. (2019) Macrophage Spa-tial Heterogeneity in Gastric Cancer Defined by Multiplex Immunohistochemistry. Nature Communications, 10, 3928. [Google Scholar] [CrossRef] [PubMed]
[26] Binenbaum, Y., Fridman, E., Yaari, Z., et al. (2018) Transfer of miRNA in Macrophage-Derived Exosomes Induces Drug Resistance in Pancreatic Adenocarcinoma. Cancer Research, 78, 5287-5299. [Google Scholar] [CrossRef] 
[27] Zhuang, H., Dai, X., Zhang, X., et al. (2020) Sophoridine Suppresses Macrophage-Mediated Immunosuppression through TLR4/IRF3 Pathway and Subsequently Upregulates CD8+ T Cytotoxic Function against Gastric Cancer. Biomedicine & Pharmacotherapy, 121, Article ID: 109636. [Google Scholar] [CrossRef] [PubMed]
[28] Wang, X., Jiao, X., Meng, Y., et al. (2018) Methionine Enkephalin (MENK) Inhibits Human Gastric Cancer through Regulating Tumor Associated Macrophages (TAMs) and PI3K/AKT/mTOR Signaling Pathway inside Cancer Cells. International Immunopharmacology, 65, 312-322. [Google Scholar] [CrossRef] [PubMed]
[29] Yamaguchi, T., Fushida, S., Yamamoto, Y., et al. (2017) Low-Dose Paclitaxel Suppresses the Induction of M2 Macrophages in Gastric Cancer. Oncology Reports, 37, 3341-3350. [Google Scholar] [CrossRef] [PubMed]
[30] Cassier, P.A., Italiano, A., Gomez-Roca, C.A., et al. (2015) CSF1R In-hibition with Emactuzumab in Locally Advanced Diffuse-Type Tenosynovial Giant Cell Tumours of the Soft Tissue: A Dose-Escalation and Dose-Expansion Phase 1 Study. The Lancet Oncology, 16, 949-956. [Google Scholar] [CrossRef] 
[31] Aldinucci, D. and Casagrande, N. (2018) Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer. International Journal of Molecular Sciences, 19, 1477. [Google Scholar] [CrossRef] [PubMed]
[32] Zang, X., Zhang, X., Hu, H., et al. (2019) Targeted Delivery of Zoledronate to Tumor-Associated Macrophages for Cancer Immunotherapy. Molecular Pharmaceutics, 16, 2249-2258. [Google Scholar] [CrossRef] [PubMed]

为你推荐